Rating neurologic impairment in multiple sclerosis

@article{Kurtzke1983RatingNI,
  title={Rating neurologic impairment in multiple sclerosis},
  author={J. Kurtzke},
  journal={Neurology},
  year={1983},
  volume={33},
  pages={1444 - 1444}
}
  • J. Kurtzke
  • Published 1983
  • Medicine
  • Neurology
  • One method of evaluating the degree of neurologic impairment in MS has been the combination of grades (0 = normal to 5 or 6 = maximal impairment) within 8 Functional Systems (FS) and an overall Disability Status Scale (DSS) that had steps from 0 (normal) to 10 (death due to MS). [...] Key Method A new Expanded Disability Status Scale (EDSS) is presented, with each of the former steps (1,2,3 . . . 9) now divided into two (1.0, 1.5, 2.0 . . . 9.5).Expand Abstract

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    An important mechanism responsible for clinical recovery after neurological damage of different types is synaptic plasticity. Nervous tissue can enhance or de-energize inter… Expand
    ConditionsBrain Injuries
    InterventionBehavioral, Drug
    INTERVENTIONAL CLINICAL TRIAL
    The purpose of this study is to explore the safety, tolerability and activity of Nivolumab, a PD-1 inhibitor, in cohorts of patients with autoimmune disease. Two cohorts of patients will… Expand
    ConditionsAutoimmune Diseases, Crohn Disease, Giant Cell Arteritis, (+7 more)
    InterventionDrug
    INTERVENTIONAL CLINICAL TRIAL
    This randomized controlled trial will evaluate a web-based relapse management programme, which is easily accessible for people with multiple sclerosis. The trial is accompanied by a… Expand
    ConditionsMultiple Sclerosis, Relapsing-Remitting
    InterventionBehavioral
    INTERVENTIONAL CLINICAL TRIAL
    Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) affecting roughly 900,000 people in the United States that frequently results in impaired… Expand
    ConditionsMultiple Sclerosis, Relapsing-Remitting
    InterventionBehavioral
    Disability Rating Scales in Multiple Sclerosis
    • 74
    Self-Assessment of Neurologic Impairment in Multiple Sclerosis
    • 46
    • PDF